BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17070501)

  • 1. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet.
    Basso F; Amar MJ; Wagner EM; Vaisman B; Paigen B; Santamarina-Fojo S; Remaley AT
    Biochem Biophys Res Commun; 2006 Dec; 351(2):398-404. PubMed ID: 17070501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.
    Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M
    Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis.
    Meurs I; Lammers B; Zhao Y; Out R; Hildebrand RB; Hoekstra M; Van Berkel TJ; Van Eck M
    Atherosclerosis; 2012 Mar; 221(1):41-7. PubMed ID: 22196936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
    Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 2007 Jan; 48(1):114-26. PubMed ID: 17060690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.
    Ranalletta M; Wang N; Han S; Yvan-Charvet L; Welch C; Tall AR
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2308-15. PubMed ID: 16917103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary phytosterol does not accumulate in the arterial wall and prevents atherosclerosis of LDLr-KO mice.
    Bombo RP; Afonso MS; Machado RM; Lavrador MS; Nunes VS; Quintão ER; Koike M; Catanozi S; Lin CJ; Nakandakare ER; Lottenberg AM
    Atherosclerosis; 2013 Dec; 231(2):442-7. PubMed ID: 24267264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.
    Yvan-Charvet L; Welch C; Pagler TA; Ranalletta M; Lamkanfi M; Han S; Ishibashi M; Li R; Wang N; Tall AR
    Circulation; 2008 Oct; 118(18):1837-47. PubMed ID: 18852364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice.
    Lammers B; Zhao Y; Foks AC; Hildebrand RB; Kuiper J; Van Berkel TJ; Van Eck M
    PLoS One; 2012; 7(10):e48080. PubMed ID: 23133551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice.
    Mo ZC; Xiao J; Tang SL; Ouyang XP; He PP; Lv YC; Long ZF; Yao F; Tan YL; Xie W; Zhang M; Liu D; Tian GP; Tang DP; Zheng XL; Zhao GJ; Tang CK
    Circ J; 2014; 78(11):2760-70. PubMed ID: 25262842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels.
    Out R; Hoekstra M; Habets K; Meurs I; de Waard V; Hildebrand RB; Wang Y; Chimini G; Kuiper J; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):258-64. PubMed ID: 18006857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
    Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
    Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.